Clinical Trials Sponsored by Ora Bio Ltd.

Total 395 results

Bio-Scaffold International Pte Ltd
National University Hospital, Singapore; Saveetha University

Completed

Radiographic Assessment of Bone Regeneration in Alveolar Sockets With PLGA Scaffold

Preservation of Alveolar Bone Height With PLGA Bioscaffold

India, Singapore
The First People's Hospital of Lianyungang
Hengrui Yuanzheng Bio-Technology Co., Ltd.

Unknown

Neo-MASCT Immunotherapy for Advanced NSCLC.

NSCLC Stage IV

China
Shenzhen Beike Bio-Technology Co., Ltd.
No.85 Hospital, Changning, Shanghai, China

Completed

Human Umbilical Cord Mesenchymal Stem Cells Transplantation for Patients With Decompensated Liver Cirrhosis

Liver Cirrhosis

China
The First Affiliated Hospital of Zhengzhou University
Techpool Bio-Pharma Co., Ltd.

Recruiting

Treatment of Acute Ischemic StroKe With Intravenous UroKinase Real-world Research: a Multicenter, Prospective Study

Acute Ischemic Stroke

China
Shanghai Unicar-Therapy Bio-medicine Technology...
Shanghai 10th People's Hospital

Recruiting

U87 CART in Treatment of Advanced Solid Tumor

Pancreatic Cancer | Solid Tumor, Adult

China
Alliancells-PuRui Biocience Co., Ltd.
Zhongyuan Union Stem Cell Bio-engineering Corporation

Unknown

Safety Study of Cord Blood-derived Cytokine-induced Killer Cells in Patients With Solid Tumor After Radical Resection

Renal Cell Carcinoma | Hepatocellular Carcinoma | Lung Cancer

China
David Pei-Cheng Lin
Grape King Bio Ltd.

Completed

Alleviating Effects Against Dry Eye by Oral Intake of Cordyceps Cicadae Mycelia

Dry Eye | Supplement
Jichi Medical University
Takara Bio Inc.; Gene Therapy Research Institution,Co.,Ltd.

Terminated

AADC Gene Therapy for Parkinson's Disease

Parkinson Disease

Japan
The First People's Hospital of Lianyungang
Hengrui Yuanzheng Bio-Technology Co., Ltd.

Unknown

MASCT-I Treatment for Advanced Solid Tumor

Solid Tumors
The First People's Hospital of Lianyungang
Hengrui Yuanzheng Bio-Technology Co., Ltd.

Unknown

Study of Apatinib and MASCT in Patients With Advanced Solid Tumors

Advanced Solid Tumors | Excluding T Cell Lymphoma

China
Shenzhen Hornetcorn Bio-technology Company, LTD
Yantai City Hospital for Infectious Diseases

Unknown

DC-CIK Combined With TACE in the Treatment of Hepatocellular Carcinoma

Neoplasms | Digestive System Neoplasms | Hepatocellular Carcinoma

China
Bird Rock Bio, Inc.
Techtrials Pesquisa e Tecnologia Ltda; Pharmagenix

Withdrawn

Study Evaluating Gerilimzumab´s Safety/Efficacy for Patients MTX or TNFα Antagonist Failed in Rheumatoid Arthritis

Rheumatoid Arthritis
Seoul National University Hospital
Pharos iBio Co., Ltd.

Recruiting

Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PHI 101 for the Treatment of AML

Relapsed or Refractory Acute Myeloid Leukemia

Korea, Republic of
Shanghai Henlius Biotech
Hengenix Biotech Inc; Sanyou Biopharmaceuticals(Shanghai)Co., Ltd; Shanghai ZJ...

Withdrawn

Evaluate Safety and Pharmacokinetics of HLX70 in Healthy Adult Volunteers

COVID-19
Techpool Bio-Pharma Co., Ltd.
The First Affiliated Hospital of Guangzhou Medical University

Unknown

The Safety and Dose Response Relationship of Ulinastatin for Acute Respiratory Distress Syndrome(ARDS)

Acute Respiratory Distress Syndrome

China
Axovant Sciences Ltd.
Oxford BioMedica

Terminated

Long Term Safety and Efficacy Study of ProSavin in Parkinson's Disease

Parkinson's Disease

France, United Kingdom
Kaohsiung Medical University Chung-Ho Memorial...
OTA HYDROGEN SOLUTIONS LTD.

Recruiting

Effectiveness Verification of Using Hydrogen Inhalation to Improve Fatigue, Pain and Quality of Life in Cancer Patients (hydrogen)

Quality of Life | Pain | Head and Neck Cancer | Sleep | Inhalation; Gas

Taiwan
Seoul National University Hospital
Pharos iBio Co., Ltd.

Recruiting

Chk2 Inhibitor for Recurrent EpitheliAl periToneal, fallopIan or oVarian cancEr (CREATIVE Phase IA Trial) (CREATIVE)

Platinum-resistant Ovarian Cancer | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-refractory Ovarian Carcinoma

Korea, Republic of
Vikel Ltd
Abertawe Bro Morgannwg University NHS Trust

Unknown

Tonicity Monitor For Epilepsy and Hypertonic Disorders

Epilepsy

United Kingdom
Ori Galante
BSP Biological Signal Processing Ltd.

Completed

Usefulness of High-frequency QRS Analysis in the Evaluation of Patients With Chest Pain

Chest Pain | Acute Coronary Syndrome | Unstable Angina | STEMI | NSTEMI

Israel
Po-Lin Chen, MD
Grape King Bio Ltd.

Completed

Probiotics for Liver Cirrhosis With Portal Hypertension

Liver Cirrhosis | Portal Hypertension

Taiwan
Shenzhen Hornetcorn Bio-technology Company, LTD
Affiliated Cancer Hospital & Institute of Guangzhou Medical University

Unknown

D-CIK Combined With Chemotherapy for Non-Small Cell Lung Cancer(NSCLC)

Lung Cancer | Non-small Cell Lung Cancer

China
Shenzhen Hornetcorn Bio-technology Company, LTD
Affiliated Cancer Hospital & Institute of Guangzhou Medical University

Unknown

Autologous Tumor Tissue Antigen-sensitized DC-CIK Cells Combined With Chemotherapy for Esophageal Cancer

Neoplasms | Digestive System Neoplasms | Esophageal Cancer | Esophageal Neoplasms

China
Shenzhen Beike Bio-Technology Co., Ltd.
The Second Affiliated Hospital of Kunming Medical University

Unknown

Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy

China
AIO-Studien-gGmbH
Roche Pharma AG; Immodulon Therapeutics Ltd

Recruiting

Atezolizumab in Patients With MSI-h/MMR-D Stage III Colorectal Cancer Ineligible for Oxaliplatin (ANTONIO)

Colorectal Cancer

Germany
Shenzhen Hornetcorn Bio-technology Company, LTD
The Fifth Affiliated Hospital of Guangzhou Medical University

Completed

Human Umbilical Cord Mesenchymal Stem Cell Transplantation in Articular Cartilage Defect

Osteoarthritis | Cartilage Diseases

China
Shenzhen Beike Bio-Technology Co., Ltd.
The Second Affiliated Hospital of Kunming Medical University

Unknown

Allogenic Stem Cell Therapy in Patients With Acute Burn

Burns

China
Pfizer
Parexel; SACT INTERNATIONAL Co., LTD.; Acronet; Bellsystem24 , Inc.; Mitsubishi Kagaku... and other collaborators

Completed

Dalacin-T Gel Post Approval Study

Acne Vulgaris
Shenzhen Hornetcorn Bio-technology Company, LTD
The Fifth Affiliated Hospital of Guangzhou Medical University

Unknown

Human Umbilical Cord Mesenchymal Stem Cell in Cerebral Hemorrhage Sequela

Cerebral Hemorrhage

China
Shanghai Unicar-Therapy Bio-medicine Technology...
The First Affiliated Hospital of Soochow University

Recruiting

PD-1 Silent PSMA/PSCA Targeted CAR-T for the Treatment of Prostate Cancer

Prostate Cancer

China
Shanghai Unicar-Therapy Bio-medicine Technology...
The First Affiliated Hospital of Soochow University

Recruiting

CD19 Chimeric Antigen Receptors and CD19 Positive Feeder T Cells as a Leukemia Consolidation Treatment

Acute Lymphoblastic Leukemia in Remission

China
The First Affiliated Hospital of Soochow University
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd

Recruiting

CAR-T Cell Therapy Targeting to CD19 for R/R ALL

Acute Lymphoblastic Leukemia With Failed Remission

China
The First Affiliated Hospital of Soochow University
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd

Unknown

A Study of CD19/22 CART Cells Combined With PD-1 Inhibitor in Relapsed/Refractory B-cell Lymphoma

Refractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin Lymphoma

China
iCell Gene Therapeutics
Peking University Shenzhen Hospital; iCAR Bio Therapeutics Ltd.; Chengdu Military...

Unknown

BCMA-CS1 Compound CAR (cCAR) T Cells for Relapsed/Refractory Multiple Myeloma

Multiple Myeloma

China
Shenzhen Beike Bio-Technology Co., Ltd.
Shandong Jiaotong Hospital; Association for the Handicapped Of Jinan

Completed

Safety and Efficacy of Stem Cell Therapy in Patients With Autism

Autism

China
AIO-Studien-gGmbH
Taiho Pharmaceutical Co., Ltd.; Nordic Pharma SAS

Completed

Feasibility Study of Adjuvant Treatment With S-1 in Patients After R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric Junction (S-1 adjuvant)

Adenocarcinoma,Stomach | Adenocarcinoma, Esophagogastric Junction

Germany
The First Affiliated Hospital of Soochow University
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd

Recruiting

A Study of ASCT Bridging CART Cell Therapy in Relapsed/Refractory B-cell Lymphoma

Refractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin Lymphoma

China
Shanghai Unicar-Therapy Bio-medicine Technology...
The First Affiliated Hospital of Soochow University

Recruiting

CD19/CD22-targeted Chimeric Antigen Receptor Engineered T Cell (CART) in B-Cell Acute Lymphoblastic Leukemia.

Leukemia, B-cell

China
Shanghai Unicar-Therapy Bio-medicine Technology...
The First Affiliated Hospital of Soochow University

Recruiting

CD19 CAR-T Cells With CRS Suppression Technology for r/r CD19+ Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia | Relapse | CD19 Positive | Refractory

China
iCell Gene Therapeutics
Peking University Shenzhen Hospital; iCAR Bio Therapeutics Ltd.; Chengdu Military...

Unknown

CD19 CARvac T Cells for Patients With Relapsed / Refractory B Cell Malignancies

B Cell Lymphoma | B Cell Leukemia

China
iCell Gene Therapeutics
Peking University Shenzhen Hospital; iCAR Bio Therapeutics Ltd.; Chengdu Military...

Unknown

CD123-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic Malignancies

Acute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myeloid Leukemia | Hematologic Malignancy | Myeloproliferative Neoplasm

China
The First Affiliated Hospital of Soochow University
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd

Unknown

CAR-T for R/R B-NHL

Refractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin Lymphoma | CAR - T CD19/CD20/CD22/CD30

China
Sichuan J.Z. Bio-chemical Science and Technology...
Peking University Cancer Hospital & Institute

Completed

Phase I Studies of Chlorogenic Acid for Injection for Tolerance and Pharmacokinetic of Advanced Cancers

Advanced Cancer

China
The First Affiliated Hospital of Soochow University
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd

Recruiting

Anti-BCMA CAR T-Cell Therapy for R/R ITP

ITP

China
Shanghai Unicar-Therapy Bio-medicine Technology...
The First Affiliated Hospital of Soochow University

Recruiting

Clinical Study of ssCART-19 Cells in Patients With CD19 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia

Relapsed or Refractory Acute Lymphoblastic Leukemia

China
Shanghai Unicar-Therapy Bio-medicine Technology...
The First Affiliated Hospital of Soochow University

Recruiting

CAR-T Therapy for Central Nervous System B-cell Acute Lymphocytic Leukemia

B-cell Acute Lymphocytic Leukemia

China
iCell Gene Therapeutics
Peking University Shenzhen Hospital; iCAR Bio Therapeutics Ltd.; Chengdu Military...

Unknown

CD20-CD19 Compound CAR (cCAR) T Cells for Patients With Relapsed /Refractory B Cell Malignancies

B Cell Lymphoma | B Cell Leukemia

China
First Affiliated Hospital of Harbin Medical University
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd

Unknown

Evaluate the Safety and Efficacy of CAR-T in the Treatment of Pancreatic Cancer.

Pancreatic Cancer | CAR

China
Shenzhen Hornetcorn Bio-technology Company, LTD
The Second Affiliated Hospital of University of South China

Unknown

Human Umbilical Cord-Mesenchymal Stem Cells for Pneumoconiosis

Pneumoconiosis

China
Shenzhen Hornetcorn Bio-technology Company, LTD
The Second Affiliated Hospital of University of South China

Unknown

Human Umbilical Cord-Mesenchymal Stem Cells for Hepatic Cirrhosis

Hepatic Cirrhosis

China

Clinical Trials Sponsored by Ora Bio Ltd.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Singapore

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations